Rilzabrutinib improved efficacy and QOL outcomes among pre-treated adult patients with immune thrombocytopenia.

Hydroxyurea showed more dose-limiting toxicities than placebo but reduced clinical AEs and improved hematological parameters, ...

The holiday season increases cardiac risks and reduces medical access, making proactive cardiac health strategies essential ...

Revumenib displayed promising anti-tumor activity among patients with relapsed or refractory KMT2Ar acute leukemia.

The following is a summary of “A nationwide study of two decades of invasive pneumococcal disease in the Faroe Islands, ...

Fast subjective walking speed is associated with lower odds of metabolic diseases among individuals with obesity, according ...

The following is a summary of “Prevalence, risk factors and the impact of tenofovir treatment in SARS-CoV-2 infection and ...

The following is a summary of “Effects of COVID-19 Infection on Symptom Severity and Disability in Multiple Sclerosis,” ...

Short sleep duration that persists during pregnancy and for two to seven years after delivery is associated with increased ...

Last week, President Joe Biden signed the Cardiomyopathy Health Education, Awareness, Research and Training in Schools ...

The platinum chemotherapy shortage, first announced on Feb. 10, 2023, resulted in a modest absolute reduction in platinum use ...

The following is a summary of “Role of Language in Hospital Admissions: The COVID-19 Experience in a Safety-Net Hospital ...